Bupivacaine Pharmacokinetics Following TAP Block

The Hospital for Sick Children

Status: Completed

Conditions: Transversus Abdominis Plane Block

Treatments: Other: Blood sample for bupivicaine pharmacokinetics

Study type: Observational

Funder types: Other

Identifiers

NCT02015182

1000023222

Details and patient eligibility

About

The aims of this study are to determine population PK parameters of bupivacaine in children following TAP block using a population-based PK approach, and to evaluate the influence of patient covariates on drug disposition.

Full description

The number of published pediatric studies on the use of transversus abdominis plane (TAP) block has increased in recent years. The transversus abdominis plane (TAP) block has been used for postoperative analgesia for surgery to the abdominal wall and involves the injection of local anesthetic solution into a plane between internal oblique (IO) and transversus abdominis (TA) muscles. The TAP block has the advantage of providing unilateral analgesia in instances of non-midline abdominal incision and is particularly useful in cases where epidural blockade is either contraindicated or technically or logistically not feasible. Bupivacaine and ropivacaine have been used as local anesthetics for TAP blocks in published studies to date. However, no data exist regarding the pharmacokinetics of bupivacaine after TAP block in children. The aims of this study are to determine population pharmacokinetic (PK) parameters of bupivacaine in children following a TAP block, using a population-based PK approach.

Enrollment: 20 patients

Sex: All

Ages: 3 months to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients receiving a TAP block as part of routine anesthetic management
• Patients older than 3 months and less than 18 years of age
• Patients weighing ≥ 6 kg
• Patients with American Society of Anesthesiologists (ASA) score 1-3

Exclusion criteria

• Patients with known severe preexisting liver disease
• Patients with known severe (i.e. requiring dialysis) preexisting renal disease
• Patients who will be discharged the day of surgery
• Refusal to consent

Trial design

20 participants in 1 patient group

Blood sample for bupivicaine pharmacokinetics

Description:

Children undergoing TAP block will have blood sampled for bupivacaine pharmacokinetics

Treatment:

Other: Blood sample for bupivicaine pharmacokinetics